alpha-TRAIL-R2 (Amgen/Abgenix)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namealpha-TRAIL-R2 (Amgen/Abgenix)
Drug Alias Namealpha-TRAIL-R2 (Immunex/Abgenix)alpha-TRAIL-R2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTNF-related apoptosis-inducing ligand receptors modulators
TargetsTNF-related apoptosis-inducing ligand receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunex Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen IncAbgenix IncorporatedImmunex Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A